Source: Υπουργείο Υγείας (CY) Revision Year: 2019 Publisher: Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
Intestinal candidosis: Also for use in patients who may be susceptible to candidal overgrowth e.g. patients with malignant disease especially if receiving cytotoxic drugs, and those patients receiving high doses or prolonged courses of antibiotics or corticosteroids.
The adult dose for the treatment of candidosis is one tablet four times daily, but this dose may be doubled. For prophylaxis a total daily dose of one million units has been found to suppress the overgrowth of Candida albicans in patients receiving broad-spectrum antibiotic therapy.
No specific dosage recommendations or precautions.
Oral administration.
Since absorption of nystatin from the gastro-intestinal tract is negligible, accidental ingestion causes no systemic toxicity.
3 years.
Store below 25°C. Protect from light moisture.
PVC/Aluminium blisters. Pack sizes of 20, 30 and 100 coated tablets.
PP containers with PE closure. Pack sizes of 100 and 1000 coated tablets.
Not all pack sizes may be marketed.
No special instructions.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
